Award recordCONTRACT

VANDA PHARMACEUTICALS INC.

PIID 36C25620F0270· VHA· 256-NETWORK CONTRACT OFFICE 16 (36C256)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $128,543 net obligations· UEI NG5JU1TQ3379· DC

Description

EMERGENCY - HETLIOZ (TASIMELTEON) MEDICATION

First action · last action
2020-05-13 · 2021-06-14
Transactions
2
First transaction's obligation
$124,726
Base + all options value (sum of deltas)
$128,543
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70102
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$128,543$0Base award · 2020-05-13 · this action $124,726 · running total $124,726Modification P00001 · 2021-06-14 · this action $3,818 · running total $128,543
  • Base2020-05-13+$124,726= $124,726
  • Mod P000012021-06-14+$3,818= $128,543
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-05-13+$124,726$124,726EMERGENCY - HETLIOZ (TASIMELTEON) MEDICATION
Mod P00001· OTHER ADMINISTRATIVE ACTION2021-06-14+$3,818$128,543EMERGENCY - HETLIOZ (TASIMELTEON) MEDICATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NG5JU1TQ3379)

AwardOffice · PSC / listingNet obligationsFY
36C26026F0025260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$26,344FY2026
36C26025F0002260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$131,068FY2025
36E79724A0032NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36F79724D0191NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26024F0173260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$154,049FY2024
36C26023F0431260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$77,799FY2023

Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25626N0555CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$654,692FY2026
36C25626P0618HANGER PROSTHETICS & ORTHOTICS INC256-NETWORK CONTRACT OFFICE 16 (36C256)$15,119FY2026
36C25626N0492BAYER HEALTHCARE PHARMACEUTICALS INC256-NETWORK CONTRACT OFFICE 16 (36C256)$386,860FY2026
36C25626N0469CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$396,000FY2026
36C25626N0461CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$271,226FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25620F0270_3600_V797D70102_3600 · retrieved 2026-09-27.